BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29859728)

  • 1. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
    Daneshmand S; Bazargani ST; Bivalacqua TJ; Holzbeierlein JM; Willard B; Taylor JM; Liao JC; Pohar K; Tierney J; Konety B;
    Urol Oncol; 2018 Aug; 36(8):361.e1-361.e6. PubMed ID: 29859728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
    Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
    BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
    Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
    Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study.
    Palou J; Hernández C; Solsona E; Abascal R; Burgués JP; Rioja C; Cabrera JA; Gutiérrez C; Rodríguez O; Iborra I; Herranz F; Abascal JM; Conde G; Oliva J
    BJU Int; 2015 Jul; 116(1):37-43. PubMed ID: 25496450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study.
    Lapini A; Minervini A; Masala A; Schips L; Pycha A; Cindolo L; Giannella R; Martini T; Vittori G; Zani D; Bellomo F; Cosciani Cunico S
    Surg Endosc; 2012 Dec; 26(12):3634-41. PubMed ID: 22729704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue light cystoscopy with hexylaminolevulinate: Our 7 years experience.
    Lacetera V; Cantoro U; Montesi L; Cantoro D; Cervelli B; Cicetti A; Gabrielloni G; Milella D; Montesi M; Morcellini R; Parri G; Recanatini E; Beatrici V
    Arch Ital Urol Androl; 2017 Mar; 89(1):39-41. PubMed ID: 28403596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity?
    Shore ND; Gavaghan MB
    Urol Oncol; 2023 Apr; 41(4):207.e9-207.e16. PubMed ID: 36564259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
    Bach T; Bastian PJ; Blana A; Kaminsky A; Keller S; Knoll T; Lang C; Promnitz S; Ubrig B; Keller T; Qvick B; Burger M;
    World J Urol; 2017 May; 35(5):737-744. PubMed ID: 27578233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons.
    Chappidi MR; Yang H; Meng MV; Bivalacqua TJ; Daneshmand S; Holzbeierlein JM; Kaimakliotis HZ; Konety B; Liao JC; Pohar K; Steinberg GD; Taylor JM; Tyson MD; Willard B; Lotan Y; Porten SP; Kates M
    J Urol; 2022 Mar; 207(3):534-540. PubMed ID: 34694916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAL fluorescence cystoscopy and TURB one year of Romanian experience.
    Geavlete B; Mulţescu R; Georgescu D; Jecu M; Geavlete P
    J Med Life; 2009; 2(2):185-90. PubMed ID: 20108538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy.
    Pagliarulo V; Alba S; Gallone MF; Di Stasi S; Cormio L; Petitti T; Buscarini M; Minafra P; Carrieri G
    J Endourol; 2017 Apr; 31(4):405-411. PubMed ID: 28145751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].
    Gakis G; Volkmer B; Qvick B; Marteau F; Stenzl A
    Urologe A; 2019 Jan; 58(1):34-40. PubMed ID: 29637215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.
    Pietzak EJ
    Curr Urol Rep; 2017 May; 18(5):39. PubMed ID: 28324275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hexvix induced fluorescence blue light cystoscopy--a new perspective in superficial bladder tumors diagnosis].
    Geavlete B; Mulţescu R; Georgescu D; Geavlete P
    Chirurgia (Bucur); 2008; 103(5):559-64. PubMed ID: 19260632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial experience in the diagnosis and treatment of superficial bladder tumors with Hexvix].
    Abascal Junquera JM; Hevia Suárez M; Abascal García JM; Estébanez C; Astudillo A; Abascal R
    Arch Esp Urol; 2008 May; 61(4):475-82; discussion 482-3. PubMed ID: 18592765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexvix blue light fluorescence cystoscopy--a promising approach in diagnosis of superficial bladder tumors.
    Geavlete B; Mulţescu R; Georgescu D; Geavlete P
    J Med Life; 2008; 1(3):355-62. PubMed ID: 20108513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.
    Daneshmand S; Schuckman AK; Bochner BH; Cookson MS; Downs TM; Gomella LG; Grossman HB; Kamat AM; Konety BR; Lee CT; Pohar KS; Pruthi RS; Resnick MJ; Smith ND; Witjes JA; Schoenberg MP; Steinberg GD
    Nat Rev Urol; 2014 Oct; 11(10):589-96. PubMed ID: 25245244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexaminolevulinate fluorescence cystoscopy and transurethral resection of the bladder in noninvasive bladder tumors.
    Geavlete B; Multescu R; Georgescu D; Geavlete P
    J Endourol; 2009 Jun; 23(6):977-81. PubMed ID: 19473068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancer.
    Williams SB; Gavaghan MB; Fernandez A; Daneshmand S; Kamat AM
    Urol Oncol; 2022 Jan; 40(1):10.e7-10.e12. PubMed ID: 34158205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer.
    Yang LP
    Mol Diagn Ther; 2014 Feb; 18(1):105-16. PubMed ID: 24248555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.